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The identification and tracking of antigen-specific immunoglobulin (Ig) sequences within total Ig 22 repertoires is central to high-throughput sequencing (HTS) studies of infections or vaccinations. In this 23 context, public Ig sequences shared by different individuals exposed to the same antigen could be 24 valuable markers for tracing back infections, measuring vaccine immunogenicity, and perhaps 25 ultimately allow the reconstruction of the immunological history of an individual. Here, we 26 immunized groups of transgenic rats expressing human Ig against tetanus toxoid (TT), Modified 27
Vaccinia virus Ankara (MVA), measles virus hemagglutinin and fusion proteins expressed on MVA 28 and the environmental carcinogen Benzo[a]Pyrene, coupled to TT. We showed that these antigens 29 impose a selective pressure causing the Ig Heavy chain (IgH) repertoires of the rats to converge 30 towards the expression of antibodies with highly similar IgH CDR3 amino acid sequences. We present 31 a computational approach, similar to differential gene expression analysis, that selects for clusters of 32
CDR3s with 80% similarity, significantly overrepresented within the different groups of immunized 33 rats. These IgH clusters represent antigen-induced IgH signatures exhibiting stereotypic amino acid 34 patterns including previously described TT and measles specific IgH sequences. Our data suggest, that 35 with the presented methodology, transgenic Ig rats can be utilized as a model to identify antigen-36 induced, human IgH signatures to a variety of different antigens. 37 38 Introduction 39 Immunoglobulin (Ig) molecules are the primary effectors of the humoral immune response. In theory, 40 Ig can bind to every possible antigen through the large variety of immunoglobulin V (variable), D 41
(diversity) and J (joining) gene rearrangements in the bone marrow and target-oriented affinity 42 maturation in germinal centers (1) . All B cells of a germinal center are clonally related to a common 43 ancestor and target the same antigen with varying affinities, iteratively selecting for improved affinity 44 and avidity (2). The Ig molecules of the emerging B cells bind to the target epitope in a lock-and-key 45 principle which is mediated mainly by the heavy chain complementary-determining region 3 (CDR3) 46 loop on top of the Ig (1, 3) . The CDR3 is the most variable part of the Ig sequence and the main 47
antigen-binding determinant. The repertoire of CDR3s sufficiently describes the entire functional 48 immunoglobulin heavy chain (IgH) repertoire of an individual (3, 4). 49 50
High-throughput sequencing (HTS) has been widely applied to study the IgH repertoire in response to 51 vaccination and infection (5) . With this technique, it has become possible to investigate the 52 evolutionary affinity maturation processes after antigenic challenge and to compare their outcome 53 across individuals (6). The IgH repertoire is essentially private (7), but it appears that individuals also 54 produce a public response to a common antigenic stimulus characterized by a certain degree of 55 similarity at the CDR3 sequence level (8-11). Studies investigating this concept of public Ig CDR3s 56 mainly used human blood-derived PBMCs. These represent only a miniscule part of the complete Ig 57 repertoire (12) and it is critical to capture the affinity-matured B cells during their brief transit from the 58 germinal centers through peripheral blood to the bone marrow. Public CDR3s were identified in 59 humans in response to dengue infection, H1N1 seasonal influenza vaccination and repetitive 60 polysaccharide antigens (5, 11, 13). Such CDR3s provided signatures of past immunological 61 exposures allowing for sequence-based monitoring of vaccination or infectious diseases, and perhaps 62 ultimately to reconstruct an individual's antigenic history. 63 64
Here we applied HTS on bone marrow B cells rich in serum antibody producing plasma cells from rats 65 carrying human germline IgH and light chain (IgL) loci, the OmniRat TM (14-17). These transgenic rats 66
were immunized with viral (Modified Vaccinia virus Ankara, MVA), protein (measles virus  67 hemagglutinin and fusion proteins, HF and Tetanus toxoid, TT) and chemically defined hapten-68 conjugate antigens (Benzo[a]Pyrene-TT, BaP-TT) to study the evolution of convergent CDR3 amino 69 acid sequences. We showed that OmniRat TM mount convergent Ig responses characterized by CDR3s 70 with high amino acid sequence similarity. The level of similarity was consistent for all investigated 71
antigens. We applied an approach similar to differential expression analysis to identify 72 overrepresented clusters of highly similar, antigen-driven CDR3s. These could be grouped into 73
antigen-associated signatures matching previously described measles virus hemagglutinin-specific 74
OmniRat TM hybridomas (18) and human TT-specific antibodies (13, 19-21). Our results suggested that 75
humanized Ig transgenic rats can be used as a model to study human-like Ig repertoire dynamics and 76
to determine antigen-associated CDR3 signatures to characterize the history of antigen exposure in 77 human individuals. 78
Materials and Methods

79
Animals and immunizations 80 Humanized Ig transgenic rats (OmniRat TM , Open Monoclonal Technology Inc., Palo Alto, USA) were 81 developed and bred as previously described (14-17). Animals were separated into 6 groups of 4 to 6 82 individuals. They received 3 intraperitoneal injections at 2-weeks intervals and were sacrificed 7 days 83 after the last injection. Quality control and sequence annotation 123 BAM files were extracted from the Torrent Suite TM software (version 4.0.2, standard settings) and 124 demultiplexed by multiplex identifiers (MID). Only reads with an unambiguously assigned MID (0 125 mismatches), identified primers at both ends (2 mismatches allowed) and more than 85% of the bases 126 with a quality score above 25 were considered for further analysis. After clipping MIDs and primers, 127 sequences were collapsed and submitted to the ImMunoGeneTics database (IMGT) HighV-QUEST 128 webserver (www.imgt.org, (27)) for IgHV gene annotation and CDR3 delineation (28). IgHV and IgHJ 129 genes for the in-frame, productive sequences were subsequently assigned using a local installation of 130 IgBlast (29), including only the genes present in the genome of the OmniRat TM as references. Only 131 sequences with an unambiguously assigned IgHV and IgHJ gene were considered for further analysis. 132
CDR3 similarity threshold for public immune responses 133
The number of matches for the 200 most frequent CDR3s (top 200) of a rat A in a rat B was obtained 134 for a series of similarity thresholds and returned as ratio from 0 to 1 (i.e. all top 200 CDR3s of rat A 135 have a match in rat B). Ratios were determined from 50% to 100% sequence similarity in one percent 136 increments. The averages for the top 200 matching ratios at each increment were then calculated for all 137 rats within a vaccination group and all rats vaccinated with unrelated antigens. Rats with related 138 antigens were excluded in the pairwise comparison (e.g. MVA as intra-group for MVA-HF). The 139 average top 200 matching ratios were plotted against sequence similarity along with the first 140 derivatives in GraphPad Prism 5 (www.graphpad.com). 141 142 Only CDR3s longer than 4 amino acids were included in the analysis. CDR3s with a minimum of 80% 143 amino acid similarity, were considered as relatives. One amino acid length difference was allowed, to 144 account for insertion and deletions introduced by SHM and occasional differential CDR3-IgHJ region 145 alignments by IMGT (30, 31). These length difference was penalized the same way as a substitution. 146
Identification of antigen-driven CDR3 clusters
For each CDR3, the cumulative count of all its 80% relatives per rat (CDR3-count) was calculated and 147 stored in a fuzzy match count table. Data was imported and analyzed with DESeq2 according to the 148 standard workflow for RNA-seq, treating CDR3-counts as expression values (32). Briefly, data was 149 imported as a count-data matrix and converted into a DESeq2-object with conditions according to the 150 antigens used for vaccination. Correct sample grouping was confirmed using variance stabilizing 151 transformed count data (VST-counts). Euclidian distance computation was performed on VST-counts 152 as described in the DESeq2 vignette (33). Principle component analysis plots were generated using the 153 'PlotPCA' function on VST-counts of the DESeq2 package. P-values were adjusted for multiple testing 154
and to determine the false discovery rate (FDR) using Benjamini-Hochberg correction (34). Based on 155
an FDR of 1%, over-represented CDR3 sequences were extracted if their adjusted p-values were lower 156 than 0.01. Log2-fold change cut-offs were determined manually per antigen group. The extracted 157 CDR3 sequences were grouped using single-seed iterative clustering based on maximum difference of 158 80% sequence similarity. All analytical scripts were written in Python 2.7 and R 3.2.3 (35). 159 3D modeling 160 Selected Ig nucleotide sequences were uploaded to IMGT for annotation. Sequences were elongated to 161 full length by adding the missing nucleotides from the closest germline gene as predicted by the IMGT 162 algorithm. Full length sequences were submitted to the "Rosetta Online Server that Includes 163
Everyone" (ROSIE, http://rosie.rosettacommons.org/, (36-38)) with enabled H3 loop modeling option. 164 ROSIE-output PDB files of the grafted and relaxed models were visualized using PyMol (version 165 1.7.4, http://pymol.org, (39)). 166
Results
167
High-throughput sequencing of OmniRat TM IgH mRNA transcripts 168 To study convergent IgH repertoires in response to vaccination, 32 transgenic IgHumanized rats 169 (OmniRat TM ) were immunized with different antigens ( Table 1 ; TT, BaP-TT, MVA, MVA-HF). 170
Aluminum hydroxide (ALUM) was used as an adjuvant for TT and BaP-TT. Two control groups 171 received either the adjuvant alone or were left untouched (NEG). All animals exhibited a specific 172 antibody response against the immunizations and mock immunized (ALUM group) and non-173 immunized animals (NEG group) showed no detectable antigen-specific antibodies (Supplemental 174 Fig. S1 ). MVA-HF and BaP-TT vaccinated animals exhibited a specific immune response against the 175 MVA vector or the TT carrier protein respectively, albeit at lower levels than the animals immunized 176
with these antigens only (Supplemental Fig. S1 ). Unique and highly similar CDR3 sequences in response to the same antigen 185 We first investigated to what extent rats that received the same antigen expressed the same CDR3 186 amino acid sequences. Pairs of rats from different vaccination groups (369 pairs) shared less CDR3s 187 with each other than pairs of rats within the same group (71 pairs, p-value < 2×10 -16 , Kruskal-Wallis 188
with Nemenyi post-hoc test) or immunized with related antigens (56 pairs, p-value = 3.4×10 -14 ), 189
indicating that mutual CDR3s are essentially induced by the immunizations (Fig. 1) . Among a total of 190 11,643 identical CDR3s (i.e. 100% similarity) that were shared by any set of two or more rats 191
irrespective of the antigen, 5,346 CDR3s (45.9%) were shared exclusively by animals of the same 192 group and 1,912 (16.4%) were shared between animals immunized with a related antigen (TT and  193 BaP-TT, MVA and MVA-HF). Most of the CDR3s shared within groups were common to only two 194 animals of the same group (6,467; 89.1% of CDR3s shared within groups only). CDR3s present in all 195 animals of a group were rare (Table 2) . However, multiple CDR3s which differed only by one or two 196 amino acids were shared by all animals within a vaccination group but not by animals from other 197 groups (Table 3) . Interestingly, these differences occurred preferentially at certain positions of a 198 CDR3 amino acid sequence. This suggested that the vaccinations seemed to have induced identical 199
CDR3s as well as clusters of highly similar CDR3s. 200
Shared antigen-related CDR3s at 80% sequence similarity. 201 We compared CDR3s within and across the different vaccination groups to estimate the degree of 202 similarity between these antigen-related clusters. We determined which of the top 200 CDR3s of any 203 rat A had a related CDR3 in a rat B either within the same group (intra-group comparison) or between 204 groups (inter-group comparison) allowing for a single amino acid substitution. The same analysis was 205 repeated for two, three and up to eight amino acid substitutions. The number of top 200 CDR3s found 206
to be present inter-and intra-group were plotted against the amino acid substitutions expressed as 207 percent of CDR3 length ( Fig. 2A, Supplemental Fig. S2) . The resulting sigmoidal curves showed a 208 similar shape for all vaccination groups. In the exponential phase between 100% and 90-95%, intra-209 group overlap was higher than inter-group overlap. In the linear phase between 90-95% and 75%, 210 overlap increased faster for the inter-group comparison. In the asymptotic phase below 75% similarity, 211
both inter-and intra-group overlap leveled off towards 1, indicating that all top 200 CDR3s of a rat 212 had relatives in any other rat, irrespective of the antigen administered. The first derivatives of the 213 curves showed that in all cases the inflection point was at around 80% ( Fig. 2B, Supplemental Fig.  214  S2) . Thus, at this similarity threshold a maximum number of related CDR3s can be found within the 215 same group while keeping the number of related CDR3s between groups at a minimum. In conclusion, 216 all antigens induced in these rats a public IgH response that can best be characterized by clusters of 217
CDR3s with at least 80% similarity. 218
Hierarchical clustering of CDR3 repertoires at 80% sequence similarity 219 Based on the above observation, we identified antigen-driven CDR3s using a workflow developed for 220 differential gene expression analysis of RNA-seq data (32). For each CDR3 within a rat, counts of 221 CDR3 sequences with 80% similarity (CDR3-counts) were used analogous to RNA-seq read counts. 222
Rats of the same vaccination group were considered as replicates. The CDR3-counts followed a 223 negative binomial distribution (Fig. 3A) . Compared to RNA-seq data, CDR3s usually lack a baseline 224 expression and are essentially private, resulting mostly in zero-counts for individuals across the study, 225
while some shared CDR3s have very high counts in a single animal (Fig. 3B) . To account for this 226 distribution, we applied variance stabilizing transformation (VST) to the CDR3-counts reducing the 227 variance of the standard deviations over ranked means (Fig. 3C) . Hierarchical clustering of VST-228 counts revealed three clusters (Fig. 3D) . Cluster I included all animals immunized with MVA (with or 229 without MV HF protein expression). Interestingly, within this cluster, animals of the MVA-HF group 230
and of the MVA group emerged from two separate branches indicating, that additional presentation of 231 HF antigens leaves a distinct imprint in the CDR3 repertoire. Cluster II contained the three groups of 232 animals that received alum as an adjuvant (TT, BaP-TT and ALUM). Again, each of the three groups 233 clustered on separated sub-branches. Cluster III contained only untreated animals (NEG group) and 234 was distinct from all immunized animals. The low variance and the specific grouping of the samples 235 through both principle components showed that the VST-counts cluster the data by vaccination group. 236
This indicated that the different antigens had distinct impact on a subset of the Ig repertoire of the rats 237 ( Fig. 3E) . When the data were reanalyzed applying an 85% or 75% threshold, the clear clustering of 238 rats by vaccination group was lost (Supplemental Fig. S3 ), thus confirming that the 80% similarity 239 threshold was optimal to identify antigen-associated responses on the CDR3 repertoire of the rats. 240
Additionally, it showed that VST CDR3-count data can be analyzed analogously to RNA-seq count 241
data. 242 243 Similar to RNA-seq expression experiments, we aimed to identify CDR3s that are differentially 244
Large numbers of antigen-associated CDR3s group into stereotypic signatures
represented between groups of rats. Based on a false discovery rate (FDR) of 1%, 16,727 of the 245 249,657 (6.9%) unique CDR3s across all groups were found to be overrepresented. One hundred-fold 246 differences in numbers of overrepresented CDR3s were identified in each of the six antigen-groups 247
( Table 4 ). The highest number of overrepresented CDR3s was found in the two combined groups 248
MVA and MVA-HF (n=11,080, 10.4% of the unique CDR3s for this combined group), and TT and 249
BaP-TT (n=2,451, 4.4%), which reflected the high immunogenicity of the antigens TT and MVA 250 common within these groups. Less overrepresented CDR3s were found in the MVA (n=1,689, 2.6%), 251
the MVA-HF (n=804, 1.8%) and TT group (n=540, 1.8%). The lowest number of overrepresented 252
CDR3s was found in the BaP-TT group (n=163, 0.6%). These overrepresented CDR3s could be 253 considered group-specific, and thus immunization induced. 254
Overrepresented CDR3s were grouped into clusters of 80% sequence similarity (Fig. 4) . The larger the 255 antigen, the more clusters were found. For instance, 20 clusters were found for the BaP-hapten while 256 109 clusters were found for the TT protein (46 for TT alone, and 63 for TT and BaP-TT combined). 257
The largest number of clusters was found for the MVA virus antigen (518, with 99 for MVA alone and 258 419 for MVA and MVA-HF combined). These complex antigen-driven clusters of CDR3s, typical for 259 each group, represented up to 46.5% of the bone marrow IgH repertoire of the rats (Fig. 5) . The 260 fraction of the repertoire corresponding to these CDR3 clusters varied between the groups but was 261 relatively consistent among animals of the same antigen-group. All together we showed that 262
OmniRat TM exhibited large fractions of highly similar, stereotypic CDR3s in response to the applied 263 vaccinations, even across groups with shared antigens. 264
Stereotypic signatures match known MV-specific and TT-specific CDR3s
265
MVA-HF signatures were compared to the previously described CDR3s of MV-specific hybridoma 266 clones derived from an independent set of OmniRat TM immunized with whole MV antigen (18). The 267
largest of the identified HF associated clusters (244 members) matched three CDR3s of MV-specific 268 hybridoma cells, suggesting that this cluster is an MV-H or F protein induced CDR3 signature (Fig.  269  6) . Similarly, our TT-associated clusters were compared to known human TT-specific IgH sequences 270 (13, 19-21). The CDR3s from the TT-associated cluster 4 matched 12 published human CDR3s (Fig.  271  7A) . This OmniRat TM CDR3 signature as well as the human CDR3s consisted of 15-mer CDR3s 272
following the same amino acid pattern. Both humans and rats elicited a conserved paratope defined by 273 a static motif '+QWLV' (ൌ
R / K
) at the center of the CDR3, flanked by variable positions that are 274 connected to the torso of the CDR3 (Fig. 7B) . This indicates that similar key positions are used even 275 across species. The sequence similarity between the human and rat CDR3s ranged from 67% to 87% 276 resulting from different torso amino acid compositions at the positions flanking the conserved binding 277 motif (Fig. 7C+D) . To compare the structures of these CDR3s from human and rat origin, we 278 performed 3D-homology modeling on their Fab-fragments. Four human antibodies with available 279 heavy and light chain sequences (20) and four selected OmniRat TM heavy chain sequences paired with 280 the human light chains were modeled with Rosetta Antibody. Within the OmniRat TM -human chimeric 281
Fab-fragments, the CDR3s formed torso structures ranging from unconstrained amino acid formations 282 over short beta-sheets to rigid beta-sheet hairpin constructs (Fig. 7C) . Like the rats, human CDR3s 283 exposed the key binding residues at the very tip of the CDR3 loop by a rigid beta-sheet hairpin 284
formation of the torso that protruded out of the IgH core structure (Fig. 7D) . Together our results 285 corroborate the evolution of functionally convergent CDR3s in different individuals and by different 286 vaccines delivering the same antigen. Also, this strongly indicates that OmniRat TM and humans, albeit 287 the lower sequence similarity between their TT-associated CDR3s, produce antibodies with highly 288 homologous CDR3s in response to the same antigen. 289
Discussion
290
We analyzed more than 2,700,000 functional IgH sequences derived from the bone marrow of 291 transgenic rats expressing human B cell receptor genes immunized with different antigens. Our study 292
showed that these rats produced identical as well as highly similar CDR3 amino acid sequences in 293 response to common antigenic challenges. When shared CDR3 repertoire fractions were investigated 294 at different levels of sequence similarity, overlaps between rats from the same vaccination group were 295 optimal around 80% CDR3 amino acid similarity. Applying a differential gene expression workflow to 296 the counts of 80% similar CDR3s, we presented a novel way to identify convergent, stereotypic CDR3 297 sequences in response to an antigenic stimulus. These included known CDR3s induced by different 298 measles antigens, indicating that the identified CDR3s are specific for the measles virus H or F 299 proteins which were shared in both immunizations. In addition, our approach also identified CDR3s in 300 response to tetanus toxoid that were remarkably similar to known tetanus-specific CDR3s from human 301 samples. Our findings highlighted the presence of convergent IgH transcripts at high levels in the bone 302 marrow of the transgenic rats and that these sequences are highly similar to those of humans. 303 304
Pairs of rats within the same group shared more identical CDR3s than pairs from different groups, but 305 very few CDR3s were shared among all rats of a group. Given the tremendous size and diversity of the 306
Ig repertoire, finding identical sequences in several individuals is indeed unlikely (40). Because of 307 private processes during B cell development including stochastic affinity maturation of the Ig 308 molecules, a certain variability in CDR3s converging towards reactivity with the same antigen is to be 309 expected (6, 41, 42). Galson et al. found that for the identification of public repertoires in humans an 310 87.5-91.6% cut-off (1 in 12 to 1 in 8 amino acids) was optimal to identify TT-and influenza-related 311 CDR3 clusters (43). In the present study, we explored the relation between CDR3 sequence similarity 312 and the overlap between CDR3 repertoires, by inter-and intra-group cross-comparisons at different 313 levels of sequence similarity. Our data showed that 80% amino acid similarity optimized the intra-314 group overlap between CDR3 repertoires while keeping the inter-group overlap at a minimum. The 315
identified antigen-associated clusters were absent in rats outside immunization groups, which provides 316 a strong support for their underlying biological relevance. 317 318 We showed that between 6% and 46% of the bone marrow IgH repertoire correspond to convergent 319 CDR3 sequences. Similar proportions (15-50%) of antigen-specific CDR3 sequences were reported in 320 peripheral blood B cells of patients with acute dengue infections (5). In contrast, in the reconvalescent 321 dengue patients as well as in influenza patients, convergent sequences represented only to less than 1% 322 of peripheral B cell sequences. Such human studies are normally restricted to peripheral blood where 323 only a small fraction of the repertoire can be found and assessed (12). In mice, elevated levels (37%) 324 of public clones were observed in response to HBsAg and less to NP-HEL (22%) and OVA (14%) 325 when examining bone marrow derived long-lived plasma cells (CD138 + CD22 -MHCII -CD19 -IgM -326 PI -) (44). Here, we analyzed Ig mRNA from bulk rat bone marrow cell isolates, an organ rich in serum 327
antibody-producing long-lived plasma cells (45). Because long-lived plasma cells with high levels of 328
Ig mRNA and only class switched BCR (IgG) were targeted, those are overrepresented in our datasets 329 (42, 43) . This explains the high levels of converging CDR3s in the bone marrow. We thus primarily 330 target antigen-associated effector B cells, facilitating the tracking of antigen-specific sequences 331 induced by similar antigens. 332 333
Potential influence on the repertoire composition could also result from PCR amplification biases 334 introduced during library preparation as well as sequencing errors (46). We did not account for 335 potential errors and sequencing bias by using molecular barcodes or similar methods (47-50). 336
However, the data analysis of the present study was based on collapsed, unique nucleotide Ig 337 sequences, minimizing the influence of potential PCR amplification bias. Analysis of the nucleotide 338 sequences before and after collapsing to unique nucleotide sequences revealed no major difference in 339 our findings, indicating that PCR amplification bias did not falsifying our results. The IonTorrent 340 PGM sequencing platform is prone to insertion and deletion errors, especially within homopolymer 341 repeats (51 We found that certain CDR3s have high counts of 80% relatives within a group but very few to none 358 in the unrelated groups. This is in principle comparable to differential gene expression in RNA-seq 359
data. The CDR3-counts followed a negative binomial distribution but, unlike in RNA-seq 360 experiments, our data contained large amounts of CDR3s with zero-counts over different samples. 361
These correspond to private CDR3s that are absent in other rats of the same or other groups. On the 362 other hand, some CDR3s exhibited very high counts of 80% relatives within an animal. While such a 363 data distribution is uncommon in RNA-seq, they were nevertheless compatible with our computational 364 approach (DESeq2, (32)) as demonstrated by negative binomial data distribution and perfect sample 365 grouping after variance stabilizing transformation of the CDR3-counts. Interestingly, the Euclidian 366 distance grouping of MVA-HF and MVA rats remained unchanged for 85% and even for 75% CDR3-367
counts in contrast to TT-associated rats. Similarly, Trück et al. found highly similar (≤ 2 mismatches) 368
Hib-and TT-related sequences enriched seven days post-vaccination, but could not identify H1N1-369
and MenC-related sequences at the same threshold (13). Correspondingly, statistical evidence of 370 convergent CDR3s in pairs of donors against influenza with a mean genetic distance of ~75% were 371 reported (52). Together with our data this indicated that the identification of convergent Ig repertoire 372 responses using amino acid similarity thresholds was applicable. Future research will tell to what 373 extent the 80% threshold can be applied to other antigens. 374 375
Identified convergent CDR3 matched to sequences of previously described human monoclonal 376 antibodies against TT protein (13, 19-21). Despite the relatively low sequence similarity (67% to 377 87%) between OmniRat TM and human TT-specific CDR3s, they shared a common sequence and 378 structural motif at the center of the CDR3. The center part of the CDR3 is exposed at the tip of the 379 loop structure which directly interacts with the antigen while the adjacent amino acids act as a 380 supporting scaffold. Similarly, Victor Greiff and coworkers observed stereotypical motifs at the center 381 of the CDR3 amino acid sequences in specific antibodies following NP vaccination in mice (53). 382
While structural similarity cannot readily be used to determine antibody specificity, algorithms to 383 identify convergent CDR3s could be further improved by including structural parameters drawn from 384 the expanding amount of available crystal structures. 385 386
In conclusion, we demonstrated a strong public IgH response with converging and overlapping CDR3 387 repertoires in animals exposed to the same antigens. These converging repertoires consisted of similar 388 CDR3 sequences that can be best described using an 80% amino acid similarity threshold. 389
Additionally, we presented an approach to identify such CDR3s by adopting a group-wise expression 390 analysis, similar to RNA-seq approaches. This provides also a valuable tool for large-scale HTS data-391 mining to identify potential candidates for high-affinity targeted antibody design. 392 393 Table 1 Study design: antigen and vaccination groups. TT used in the BaP-TT vaccination group was 591 chemically modified during the coupling process and therefore does not present the same antigenic 592 surface as native TT in the TT group. 593 Table 3 : Selected CDR3 sequences shared by rats in the MVA-HF group only 597
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